CBD API Market Size, Share & Trends Analysis Report By Source Type (Natural CBD API (Plant-Derived),Synthetic CBD API), By End Use / Application (Pharmaceuticals, Nutraceuticals & Dietary Supplements, Cosmetics & Personal Care, Research & Development / Clinical Use), By End User (Pharmaceutical & Biotech Companies, Nutraceutical / Supplement Manufacturers, Cosmetic & Personal Care Companies, Contract Manufacturing Organizations (CMOs) / CDMOs, Research Institutions & CROs), By Purity / Grade, By Form / Composition, By Region and By Segment Forecasts, 2025-2034

Report Id: 1478 Pages: 180 Last Updated: 10 November 2025 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of CBD API Market :

CBD API Market, By Source Type-

  • Natural CBD API (Plant-Derived)
  • Synthetic CBD API

 CBD API Market

CBD API Market, By End Use / Application-

  • Pharmaceuticals
  • Nutraceuticals & Dietary Supplements
  • Cosmetics & Personal Care
  • Research & Development / Clinical Use

CBD API Market, By Purity / Grade-

  • Pharmaceutical-Grade (≥99% purity, GMP-certified)
  • Industrial / Technical Grade (85–98% purity)

CBD API Market, By End-User-

  • Pharmaceutical & Biotech Companies
  • Nutraceutical / Supplement Manufacturers
  • Cosmetic & Personal Care Companies
  • Contract Manufacturing Organizations (CMOs) / CDMOs
  • Research Institutions & CROs

CBD API Market, By Form / Composition-

  • CBD Isolate (Pure CBD, no other cannabinoids)
  • Broad-Spectrum CBD (Multiple cannabinoids, THC-free)
  • Full-Spectrum CBD (Includes trace THC <0.3%)

CBD API Market, By Region, 

North America-

  • The US
  • Canada

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Chapter 1.    Methodology and Scope
1.1.    Research Methodology
1.2.    Research Scope & Assumptions

Chapter 2.    Executive Summary

Chapter 3.    Global CBD API Market Snapshot

Chapter 4.    Global CBD API Market Variables, Trends & Scope
4.1.    Market Segmentation & Scope
4.2.    Drivers
4.3.    Challenges
4.4.    Trends 
4.5.    Investment and Funding Analysis 
4.6.    Porter's Five Forces Analysis
4.7.    Incremental Opportunity Analysis (US$ MN), 2025-2034 
4.8.    Global CBD API Market Penetration & Growth Prospect Mapping (US$ Mn), 2023-2031
4.9.    Competitive Landscape & Market Share Analysis, By Key Player (2023)
4.10.    Use/impact of AI on CBD API MARKET Industry Trends 

Chapter 5.    CBD API Market Segmentation 1: By Source Type, Estimates & Trend Analysis
5.1.    Market Share by Origin, 2024 & 2034
5.2.    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Origin:

5.2.1.    Natural
5.2.2.    Synthetic

Chapter 6.    CBD API Market Segmentation 2: By Product, Estimates & Trend Analysis
6.1.    Market Share by Product, 2024 & 2034
6.2.    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Product:

6.2.1.    Full spectrum CBD
6.2.2.    Broad-spectrum CBD
6.2.3.    CBD isolate
6.2.4.    Water Dispersible CBD Powder
6.2.5.    Others

Chapter 7.    CBD API Market Segmentation 3: By Indication, Estimates & Trend Analysis
7.1.    Market Share by Indication, 2024 & 2034
7.2.    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following Indication:

7.2.1.    Alzheimer's Disease
7.2.2.    Autism
7.2.3.    Cancer
7.2.4.    Chronic Pain
7.2.5.    Epilepsy
7.2.6.    Migraine
7.2.7.    Multiple Sclerosis
7.2.8.    Schizophrenia
7.2.9.    Others

Chapter 8.    CBD API Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1.    Market Share by End-User, 2024 & 2034
8.2.    Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following End-User:

8.2.1.    Pharmaceutical Industry
8.2.2.    University and Research Institutes
8.2.3.    Others

Chapter 9.    CBD API Market Segmentation 5: Regional Estimates & Trend Analysis
9.1.    Global CBD API Market, Regional Snapshot 2024 & 2034
9.2.    North America

9.2.1.    North America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.2.1.1.    US
9.2.1.2.    Canada

9.2.2.    North America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Origin, 2021-2034
9.2.3.    North America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.2.4.    North America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.2.5.    North America CBD API Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.3.    Europe

9.3.1.    Europe CBD API Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.3.1.1.    Germany
9.3.1.2.    U.K.
9.3.1.3.    France
9.3.1.4.    Italy
9.3.1.5.    Spain
9.3.1.6.    Rest of Europe

9.3.2.    Europe CBD API Market Revenue (US$ Million) Estimates and Forecasts by Origin, 2021-2034
9.3.3.    Europe CBD API Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.3.4.    Europe CBD API Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.3.5.    Europe CBD API Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.4.    Asia Pacific

9.4.1.    Asia Pacific CBD API Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.4.1.1.    India 
9.4.1.2.    China
9.4.1.3.    Japan
9.4.1.4.    Australia
9.4.1.5.    South Korea
9.4.1.6.    Hong Kong
9.4.1.7.    Southeast Asia
9.4.1.8.    Rest of Asia Pacific

9.4.2.    Asia Pacific CBD API Market Revenue (US$ Million) Estimates and Forecasts by Origin, 2021-2034
9.4.3.    Asia Pacific CBD API Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.4.4.    Asia Pacific CBD API Market Revenue (US$ Million) Estimates and Forecasts By Indication, 2021-2034
9.4.5.    Asia Pacific CBD API Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.5.    Latin America

9.5.1.    Latin America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Country, 2021-2034

9.5.1.1.    Brazil
9.5.1.2.    Mexico
9.5.1.3.    Rest of Latin America

9.5.2.    Latin America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Origin, 2021-2034
9.5.3.    Latin America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.5.4.    Latin America CBD API Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.5.5.    Latin America CBD API Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

9.6.    Middle East & Africa

9.6.1.    Middle East & Africa CBD API Market Revenue (US$ Million) Estimates and Forecasts by country, 2021-2034

9.6.1.1.    GCC Countries
9.6.1.2.    Israel
9.6.1.3.    South Africa
9.6.1.4.    Rest of Middle East and Africa

9.6.2.    Middle East & Africa CBD API Market Revenue (US$ Million) Estimates and Forecasts by Origin, 2021-2034
9.6.3.    Middle East & Africa CBD API Market Revenue (US$ Million) Estimates and Forecasts by Product, 2021-2034
9.6.4.    Middle East & Africa CBD API Market Revenue (US$ Million) Estimates and Forecasts by Indication, 2021-2034
9.6.5.    Middle East & Africa CBD API Market Revenue (US$ Million) Estimates and Forecasts by End-User, 2021-2034

Chapter 10.    Competitive Landscape
10.1.    Major Mergers and Acquisitions/Strategic Alliances
10.2.    Company Profiles


10.2.1.    Recipharm

10.2.1.1.    Business Overview
10.2.1.2.    Key Product/Service 
10.2.1.3.    Financial Performance
10.2.1.4.    Geographical Presence
10.2.1.5.    Recent Developments with Business Strategy

10.2.2.    brains bioceutical
10.2.3.    Purisys
10.2.4.    DSM
10.2.5.    Bedrocan
10.2.6.    Vantage Hemp
10.2.7.    Eurofins
10.2.8.    BIOVECTRA Inc.
10.2.9.    EndoPure
10.2.10.    Biosyyd, UAB
10.2.11.    KD Pharma Group
10.2.12.    Folium Biosciences
10.2.13.    Kinetochem
10.2.14.    Colombian Golden
10.2.15.    Averix Bio, LLC
10.2.16.    Veranova
10.2.17.    KND Labs
10.2.18.    Jordan Process
10.2.19.    GVB Biopharma
10.2.20.    Other Players 

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
6346
Security Code field cannot be blank!

Frequently Asked Questions

The Global CBD API Market growth is predicted at a 15.8% CAGR during the forecast period for 2025-2034.

CBD API Market Companies are Axplora / Farmabios, Transo-Pharm USA LLC, Biophore India Pharmaceuticals Pvt. Ltd., Veranova, Cohance Lifesciences, Malladi Drugs & Pharmaceuticals Ltd., Noramco / Purisys, Farmhispania, SCI Pharmtech, Alkem Laboratories, Arene Lifesciences, Arevipharma, Averix Bio, Celadon Pharmaceuticals, Embio Limited, Farmakem, DSM-Firmenich, KD Pharma Group / KD Phyto, Biovectra, Hyasynth, Indena, Bedrocan, Vantage Hemp, CB21 Pharma, Brains Bioceutical, Others

CBD API Market growth is valued at US$ 521.94 Mn in 2024 and is expected to reach US$ 2233.37 Mn by 2034

Source Type, End Use / Application, End User , Purity/Grade and Form / Composition are the key segments of CBD API Market.

North American region is leading the CBD API Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying